World
Vaccine effectiveness: How do the COVID-19 vaccines compare to vaccines for other diseases?

Vaccine effectiveness: How do the COVID-19 vaccines compare to vaccines for other diseases?

Over the summer many experts were concerned that a possible COVID-19 vaccine might only be 50% effective, roughly similar to estimates of how effective the flu vaccine is. That is why the initial numbers reported by Pfizer-BioNTech and Moderna are particularly encouraging in the context of other vaccine efficacy rates.

Data from the CDC in this chart, which we've reproduced from Axios, compares the COVID-19 vaccines with those for other infectious diseases. If the 95% numbers turn out to be true and replicable then the COVID vaccines will rank among some of the most effective in modern medicine.

What does 95% effective mean?

Okay let's run some numbers using the Pfizer-BioNTech vaccine as an example. The trial involved 41,000 people, half were given the actual vaccine, half were given a placebo. At the end of the trial 170 cases of COVID-19 had been recorded in the total group. 162 of those were in the placebo group, and just 8 of them in the vaccine group. Hence the vaccinated group had 95% fewer infections = 95% effectiveness.

More World

See all World
world

UK prime minister vows to take action against Elon Musk’s X over AI-generated images of minors, as Grok limits image generation to paid users

Sir Keir Starmer has vowed to “take action” against Elon Musk’s X over its AI tool Grok producing sexualized images of children.

Speaking on Thursday, the UK premier called the images “unlawful” and urged the social media platform to “get their act together and get this material down,” as public outrage mounts over Grok generating explicit deepfakes on X.

Six themes cover GIF

Charting six major trends to keep watching in 2026

We’ve made a lot of charts this year — here are some of the biggest trends of 2025 and where we think they might go in the 12 months ahead. And no, it’s not just about AI.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.